Intellectual Property India Publishes Patent Application for Novel Imipridone Derivatives For The Treatment Of Breast Cancer Through Induction Of Cell Cycle Arrest, Apoptosis And Mitochondrial Dysfunction

MUMBAI, India, Sept. 14 -- Intellectual Property India has published a patent application (202641108085 A) filed by Jss Academy Of Higher Education And Research Jssaher on September 08, 2026, for Novel Imipridone Derivatives For The Treatment Of Breast Cancer Through Induction Of Cell Cycle Arrest, Apoptosis And Mitochondrial Dysfunction.

Inventors include S N Manjula; Salini P Nair; Madhukumari; Prabitha P; and Dithu Thekkekkara.

The application for the patent was published on September 11, 2026, under issue no. 37/2026.

Abstract: The present invention relates to novel imipridone derivatives for the treatment of aggressive cancers, particularly triple-negative breast cancer (TNBC). The derivatives are structurally optimized to target mi...